Softigel by Procaps will be attending CPhI Worldwide in Paris from 7-9 October, where our team of experts will be available to discuss mutual opportunities.
Softigel by Procaps offers product development, licensing and contract manufacturing services to the pharmaceutical, nutritional products, veterinary and cosmetics industries worldwide.
We are Latin America’s largest softgel encapsulator, with 11 billion doses of annual capacity, experience with more than 500 softgel formulations, and facilities recently approved by FDA and MHRA.
Softigel is also part of the Procaps Group, a diversified collection of Healthcare and related businesses, including soft-gel capsule manufacturing, advanced new drug delivery technologies, and a Pharmaceutical Division with a distribution network that reaches 41 countries around the world.
At CPhI, Softigel seeks new OTC consumer healthcare, generic Rx and pharma customers with collaboration opportunities in the US, other highly regulated markets or elsewhere worldwide, well suited to traditional softgel or our advanced drug delivery technologies such as UnigelTM (combination dose softgels), VersagelsTM (a new approach to vegetarian soft capsules), GummygelsTM (pharma gummies).
Join us at CPhI Worldwide, Paris Nord Villepinte, Stand #5F31, Hall 5A.